Researchers from Flinders University and the South Australian Health and Medical Research Institute (SAHMRI) have been studying ways to uncover potential new drug therapies for the common and lethal brain cancer, glioblastoma. In a new study, the team discovered that studying the genetics of healthy brain cells may provide insights into how to target vulnerabilities in glioblastoma cancer cells.
